CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 335

Change

-2.15 (-0.64)%

Market Cap

USD 0.11B

Volume

340.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.16 (-0.36%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.95 (-0.39%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-1.85 (-0.52%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

-0.14 (-0.41%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.19 (-0.47%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.50 (-0.58%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.54 (-0.47%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.19 (-2.93%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.19 (-0.39%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.24 (-0.30%)

USD 5.38B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.25% 97% N/A 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.25% 97% N/A 86% B+
Trailing 12 Months  
Capital Gain 25.92% 95% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.92% 95% A 90% A-
Trailing 5 Years  
Capital Gain 135.15% 96% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 135.15% 95% A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.85% 86% B+ 81% B-
Dividend Return 15.85% 85% B 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.86% 51% F 39% F
Risk Adjusted Return 123.27% 92% A 49% F
Market Capitalization 0.11B 30% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.